The PATfix® LNP Switcher Platform is an advanced analytical system designed for the characterization of lipid nanoparticle (LNP) formulations, supporting the development of nucleic acid therapeutics such as mRNA and pDNA vaccines. It provides comprehensive, high-resolution insights into critical quality attributes, including particle size, encapsulation efficiency, and nucleic acid integrity, adducts, enabling researchers better insights for decisions during formulation and development.
The biochromatography system with multi-detection capabilities allows for minimal sample preparation, preserving the integrity of sensitive nucleic acid payloads. Its software is 21 CFR Part 11 compliant, supporting secure data capture, reproducible reporting, and regulatory submission readiness.
Overall, the PATfix LNP Switcher Platform reduces complexity, improves workflow efficiency, and ensures reproducible, actionable data, making it an essential tool for developers of nucleic acid therapeutics and LNP-based vaccines.
